Clinical Translation of Angiogenesis Inhibitors

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2002 Oct 3

PMID 12360276

Citations 358

Authors

Robert Kerbel

Judah Folkman

Affiliations

Soon will be listed here.

Abstract

Angiogenesis inhibitors are a new class of drugs, for which the general rules involving conventional chemotherapy might not apply. The successful translation of angiogenesis inhibitors to clinical application depends partly on the transfer of expertise from scientists who are familiar with the biology of angiogenesis to clinicians. What are the most common questions that clinicians ask as they begin to test angiogenesis inhibitors in cancer clinical trials?

Citing Articles

Integrins as Key Mediators of Metastasis.

Caceres-Calle D, Torre-Cea I, Marcos-Zazo L, Carrera-Aguado I, Guerra-Paes E, Berlana-Galan P Int J Mol Sci. 2025; 26(3).

PMID: 39940673 PMC: 11816423. DOI: 10.3390/ijms26030904.

Integrated single-cell RNA sequencing reveals the tumor heterogeneity and microenvironment landscape during liver metastasis in adenocarcinoma of esophagogastric junction.

Xu J, Sadiq U, Zhao W, Xia H, Liu Y, Zhang R Front Immunol. 2025; 15():1484234.

PMID: 39850884 PMC: 11754270. DOI: 10.3389/fimmu.2024.1484234.

Targeting the Renin-angiotensin-aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review.

Pawlonka J, Buchalska B, Buczma K, Borzuta H, Kaminska K, Cudnoch-Jedrzejewska A Curr Treat Options Oncol. 2024; 25(11):1406-1427.

PMID: 39422794 PMC: 11541340. DOI: 10.1007/s11864-024-01270-9.

Population pharmacokinetic model of ABL001/CTX-009 (anti-VEGF/DLL4) in adult cancer patients with solid tumor.

Na J, Jeon J, Huh K, Yu K, Lee S, Eom J Cancer Sci. 2024; 115(12):3943-3951.

PMID: 39375952 PMC: 11611764. DOI: 10.1111/cas.16363.

Targeting the tumour vasculature: from vessel destruction to promotion.

Guelfi S, Hodivala-Dilke K, Bergers G Nat Rev Cancer. 2024; 24(10):655-675.

PMID: 39210063 DOI: 10.1038/s41568-024-00736-0.